Medical News

RSS

Health care fraud roundup: 30-year sentence for doctor upheld; KY. cracks down

An appeals court has upheld a 30-year prison term for a Medicare fraudster in Florida. Dr. Ana Alvarez-Jacinto, a Miami endocrinologist, was convicted of health care fraud and sentenced to 30 years behind bars.

22 Oct 2010

Growing up with lots of sisters makes man less sexy: Research

Growing up with lots of sisters makes a man less sexy. For rats, anyway. A new study published in Psychological Science, a journal of the Association for Psychological Science, finds that the sex ratio of a male rat's family when he's growing up influences both his own sexual behavior and how female rats respond to him.

22 Oct 2010

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Techulon Inc., a life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new, traceable DNA delivery platform created to deliver genetic medicine to cells while carrying a beacon so scientists can follow its progress.

22 Oct 2010

Researcher develops workshop method to help children deal with PTSD

A child who grows up in the midst of political conflict, such as war or terrorism, can exhibit severe emotional scars. But certain qualities, which psychologists call "resilience factors," can help overcome this adversity.

22 Oct 2010

New findings provide new clues on pathogenetic mechanisms of Alzheimer's disease

Pathological protein deposits linked to Alzheimer's disease and cerebral amyloid angiopathy can be triggered not only by the administration of pathogenic misfolded protein fragments directly into the brain but also by peripheral administration outside the brain.

22 Oct 2010

Nurses in health care facilities may perform better through harm reduction strategies: Researchers

University of Maryland School of Nursing researchers say nurses in hospitals and other health care facilities may perform better by following the lead of airlines, trucking, and nuclear plants, by limiting hours of service, ensuring prompt and definite breaks during shifts, and other scheduling strategies.

22 Oct 2010

Researcher receives grant to conduct study on brain development of children who stutter

A Michigan State University researcher is hopeful that a recent National Institutes of Health grant she received will result in better treatment options and, ultimately, better lives for children who stutter.

22 Oct 2010

Altogen Biosystems releases PEG-Liposome siRNA In Vivo Transfection Kit

Altogen Biosystems announced the release of its second generation of in vivo RNAi transfection reagent in the company's popular in vivo delivery product line: PEG-Liposome siRNA In Vivo Transfection Kit. This reagent is also compatible for in vivo transfection of other negatively charged molecules – RNA, DNA, and small proteins.

22 Oct 2010

Talecris announces publication of PROLASTIN-C study results for AAT deficiency in BML journal

Talecris Biotherapeutics today announced the publication of results from a study showing that PROLASTIN-C (Alpha1-Proteinase Inhibitor [Human]) (A1PI) is as effective as PROLASTIN (Alpha1-Proteinase Inhibitor [Human]) in raising levels of alpha-1 protein in patients with alpha1-antitrypsin (AAT) deficiency.

22 Oct 2010

Paragon Bioservices awarded contract to assist USAMRIID in vaccine development efforts

Paragon Bioservices, a Baltimore-based CMO focused on the contract research, process development and manufacturing of biologics, announced today that it has been awarded a $4.99 million contract to assist the U.S. Army Medical Research Institute for Infectious Diseases in its vaccine development efforts.

22 Oct 2010

Disparities in breast cancer mortality continues to be high in Chicago: Data

Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.

22 Oct 2010

Social networks important for maintaining dialysis patients' health: Study

Dialysis patients with little social support from friends and family are more likely to ignore doctors' orders, experience a poorer quality of life, and die prematurely, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results suggest strong social networks are important for maintaining dialysis patients' health.

22 Oct 2010

Six government drug control laboratories in MENA to join USP to improve quality of drugs

Six government drug control laboratories in the Middle East and North Africa will join together with the United States Pharmacopeial Convention in an effort to improve their capabilities to test the quality of drugs. The MENA Regional Laboratory Network aims to promote communication and exchange of information among participating countries, strengthen the performance and technical skill of the laboratories and their personnel, harmonize methods that facilitate approval of drugs across countries in the region, and help eliminate substandard and counterfeit drugs.

22 Oct 2010

Patients are under-informed about treatments; Home-based care gains popularity

A survey of more than 3,000 patients age 40 and older reveals that physicians often leave information out when they present treatment plans to patients, who "hear far more from doctors about the pros than cons of medications, tests and surgeries." Often, "physicians tend to offer opinions, not options, the researchers found, and rarely mention to patients that they can decide not to do anything," according to the study, which was funded by the Foundation for Informed Medical Decision Making.

22 Oct 2010

Cephalon signs convertible note subscription agreement with ChemGenex Pharmaceuticals

Today, Cephalon, Inc. announced the signing of a convertible note subscription agreement with ChemGenex Pharmaceuticals Limited, an Australian-based oncology focused biopharmaceutical company.

22 Oct 2010

Scientists discover new cell that may limit inflammation in CNS

Scientists at Barrow Neurological Institute have recently made discoveries about a type of cell that may limit inflammation in the central nervous system - a finding that could have important implications in the treatment of brain disorders such as multiple sclerosis. The research, led by Barrow's Fu-Dong Shi, MD, PhD, was published in the August 2010 issue of The Journal of Experimental Medicine, and simultaneously highlighted in Nature.

22 Oct 2010

FDA announces new label for HIV antiviral drug Invirase

The U.S. Food and Drug Administration today announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening side effects on the heart when used with Norvir (ritonavir), another HIV antiviral medication.

22 Oct 2010

Participants explore role of pediatric oncology nurses at APHON 34th Annual Convention

"While this is a topic most people - even nurses - avoid, it was a most informative presentation for me," said a participant in the session on "The Art of Pediatric Palliative Care Nursing" at the Association of Pediatric Hematology/Oncology Nurses 34th Annual Convention, October 14-16, 2010, in Minneapolis, MN.

22 Oct 2010

Gilead announces results from Phase III clinical trial of Cayston, TIS in cystic fibrosis patients

Gilead Sciences, Inc. today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution) versus tobramycin inhalation solution (TIS) in cystic fibrosis (CF) patients with Pseudomonas aeruginosa (P. aeruginosa) achieved its co-primary endpoint of superiority of Cayston for mean actual change in forced expiratory volume in one second (FEV1, a measure of lung function) percent predicted across three treatment cycles (six months).

22 Oct 2010

New review outlines Bionovo's platform of estrogen receptor modulators for menopausal conditions

Bionovo, Inc. today announced the publication of a review of results from studies discussing new classes of estrogen receptor modulating drugs with distinct mechanism for pharmacological effect. The review is published in the most recent edition of Current Opinion in Pharmacology.

22 Oct 2010

Medical News

Health care fraud roundup: 30-year sentence for doctor upheld; KY. cracks down

Growing up with lots of sisters makes man less sexy: Research

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Researcher develops workshop method to help children deal with PTSD

New findings provide new clues on pathogenetic mechanisms of Alzheimer's disease

Nurses in health care facilities may perform better through harm reduction strategies: Researchers

Researcher receives grant to conduct study on brain development of children who stutter

Altogen Biosystems releases PEG-Liposome siRNA In Vivo Transfection Kit

Talecris announces publication of PROLASTIN-C study results for AAT deficiency in BML journal

Paragon Bioservices awarded contract to assist USAMRIID in vaccine development efforts

Disparities in breast cancer mortality continues to be high in Chicago: Data

Social networks important for maintaining dialysis patients' health: Study

Six government drug control laboratories in MENA to join USP to improve quality of drugs

Patients are under-informed about treatments; Home-based care gains popularity

Cephalon signs convertible note subscription agreement with ChemGenex Pharmaceuticals

Scientists discover new cell that may limit inflammation in CNS

FDA announces new label for HIV antiviral drug Invirase

Participants explore role of pediatric oncology nurses at APHON 34th Annual Convention

Gilead announces results from Phase III clinical trial of Cayston, TIS in cystic fibrosis patients

New review outlines Bionovo's platform of estrogen receptor modulators for menopausal conditions

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News